WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
Belt and Road archaeological cooperation fosters closer friendship among civilizations
'Wonderstruck' superfan wins dream job as This Morning's Taylor Swift correspondent
His latest dish! James Martin, 51, is arm
Pelicans wing Brandon Ingram returns from a knee injury in regular
Lantern Festival function held for Taiwan business people on mainland
Tory rebels urge Rishi Sunak to ditch controversial smoking ban plan and other 'fundamentally un
Saudi Arabia is going to sponsor the WTA women's tennis rankings under a new partnership
China's demographic dividend is turning into talent dividend
Pentagon vows to keep weapons moving to Ukraine as Kyiv faces a renewed assault by Russia
Joel Cauchi: New details emerge about Bondi Junction knifeman that killed six